Japan's Taiyo Pharmaceutical Aims For U.S. FDA Inspection Clearance
This article was originally published in PharmAsia News
Executive Summary
Major Japanese generic drug maker Taiyo Pharmaceutical will improve its main production site based in Takayama, Gifu Prefecture in an effort to get clearance from U.S. FDA inspectors, disclosed President Aratani Shigeki during a Nov. 6 earnings call